The Ghana Health Service (GHS) has confirmed the country’s first case of Mpox, signaling a significant development in public health. Additionally, 230 suspected cases are currently under investigation across all 16 regions.
In collaboration with the World Health Organization (WHO) and other partners, the GHS has promptly launched contact tracing and isolation measures to prevent further spread of the virus. Enhanced surveillance and public education campaigns are also being conducted to raise awareness of Mpox symptoms and prevention methods.
The confirmed Mpox case was detected in one region, with the majority of the 230 suspected cases involving individuals aged 20-40 years, who are experiencing symptoms such as fever, headache, muscle aches, and the characteristic Mpox rash.
To curb the spread of Mpox, the GHS advises the public to maintain good hygiene, including frequent handwashing, and avoid close contact with individuals showing symptoms. Any suspected cases should be reported immediately to the nearest health facility. The GHS also recommends vaccination for high-risk groups, following WHO guidelines.
Ghana’s healthcare system has shown resilience in managing infectious disease outbreaks, and the swift response to the Mpox case demonstrates the country’s commitment to safeguarding public health.
Formerly known as monkeypox, Mpox has affected several countries globally, and Ghana’s confirmation highlights the ongoing need for vigilance and international cooperation in combating public health threats.
Citizens are urged to remain calm, seek accurate information from credible sources, and follow public health guidelines to help contain the spread of Mpox and ensure the well-being of the nation.
